Cargando…
Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations
Lung cancer and chronic obstructive pulmonary disease (COPD) are two major lung diseases. Epidermal growth factor receptor (EGFR) mutations, v‐Ki‐ras2 Kirsten rat sarcoma (KRAS) mutations and anaplastic lymphoma kinase (ALK) gene rearrangements represent driver mutations that are frequently assessed...
Autores principales: | Lim, Jeong Uk, Yeo, Chang Dong, Rhee, Chin Kook, Kim, Yong Hyun, Park, Chan Kwon, Kim, Ju Sang, Kim, Jin Woo, Lee, Sang Haak, Kim, Seung Joon, Yoon, Hyoung Kyu, Kim, Tae-Jung, Lee, Kyo Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640806/ https://www.ncbi.nlm.nih.gov/pubmed/26555338 http://dx.doi.org/10.1371/journal.pone.0142306 |
Ejemplares similares
-
Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients
por: Lim, Jeong Uk, et al.
Publicado: (2018) -
Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients
por: Lim, Jeong Uk, et al.
Publicado: (2019) -
Factors associated with plasma IL-33 levels in patients with chronic obstructive pulmonary disease
por: Kim, Sei Won, et al.
Publicado: (2017) -
Comparative study on medical utilization and costs of chronic obstructive pulmonary disease with good lung function
por: Lim, Jeong Uk, et al.
Publicado: (2017) -
Risk factors for the discontinuation of roflumilast in patients with chronic obstructive pulmonary disease
por: Kim, Kyung Hoon, et al.
Publicado: (2017)